Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus alfentanyl dosing for painless oocyte retrieval
ChiCTR2300076264Phase 4Not yet recruiting
- Sponsor
- Reproductive Hospital affiliated with Shandong University
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in procedural pain and anxiety disorder (4 arms), sponsored by Reproductive Hospital affiliated with Shandong University. Primary endpoint: Success rate of sedation. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
procedural painanxiety disorder
Beyond the preview
Go deeper on ChiCTR2300076264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076264.